Erythropoietin, erythropoiesis and beyond

Biochemical Pharmacology

Volumn 82, Issue 10, 2011, Pages 1291-1303

  Chateauvieux, S ^a   Grigorakaki, C ^a   Morceau, F ^a   Dicato, M ^b   Diederich, M ^a  

^a LABORATOIRE DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE DU CANCER   (Luxembourg)

^b CENTRE HOSPITALIER DE LUXEMBOURG   (Luxembourg)

Author keywords

Cardioprotection; EPO; EPO derivative; EPOR; Erythropoiesis; Neuroprotection

Indexed keywords

ANTIANEMIC AGENT; ASIALOERYTHROPOIETIN; CARBAMYLATED ERYTHROPOIETIN; CARBAMYLATED NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; CONTINUOUS ERYTHROPOIESIS RECEPTOR ACTIVATOR; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; GLUTAMIC ACID; GLUTAMINYLGLUTAMYLGLUTAMINYLLEUCYLGLUTAMYLARGINYLALANYLLEUCYLASPARAGINYLSERYLSERINE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; OXYGENASE INHIBITOR; PEGINESATIDE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE INHIBITOR; PROTEIN S 100; PROTEIN S100E; RECOMBINANT ERYTHROPOIETIN; SYNTHETIC ERYTHROPOIESIS PROTEIN; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; BIM PROTEIN; CASPASE 3; CYCLIN DEPENDENT KINASE INHIBITOR 1B; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL XL; RAF PROTEIN; RAS PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR GATA; TRANSCRIPTION FACTOR GATA 1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNINDEXED DRUG;

ACUTE HEMORRHAGIC PANCREATITIS; ANEMIA; ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; BINDING AFFINITY; BLOOD PRESSURE; BRAIN DEVELOPMENT; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; DRUG MECHANISM; DRUG RECEPTOR BINDING; EAR INJURY; ERYTHROPOIESIS; EXCITOTOXICITY; EYE PROTECTION; HEARING LOSS; HEART INFARCTION; HEART PROTECTION; HUMAN; HYPOXIA; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; MOLECULAR DYNAMICS; NEUROPROTECTION; NEUROTOXICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS DISEASE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RETINA DEGENERATION; SIDE EFFECT; THROMBOSIS; BONE REMODELING; CELL DIFFERENTIATION; CELL PROLIFERATION; DIABETIC RETINOPATHY; DRUG EFFECT; GENE EXPRESSION; HEMATOPOIETIC SYSTEM; HORMONE SYNTHESIS; KIDNEY; MICROANGIOPATHY; TISSUE INJURY; TRANSCRIPTION REGULATION; TREATMENT OUTCOME; URETHRA OBSTRUCTION;

BRAIN; ERYTHROPOIESIS; ERYTHROPOIETIN; GENE EXPRESSION REGULATION; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 80054710056     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2011.06.045     Document Type: Conference Paper

References (186)

1. J.W. Fisher, S. Koury, T. Ducey, and S. Mendel Erythropoietin production by interstitial cells of hypoxic monkey kidneys Br J Haematol 95 1996 27 32 (Pubitemid 26340225)
2. S.T. Koury, M.C. Bondurant, and M.J. Koury Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridization Blood 71 1988 524 527 (Pubitemid 18089550)
3. N. Suzuki, N. Obara, and M. Yamamoto Use of gene-manipulated mice in the study of erythropoietin gene expression Methods Enzymol 435 2007 157 177
4. S. Frede, P. Freitag, L. Geuting, R. Konietzny, and J. Fandrey Oxygen-regulated expression of the erythropoietin gene in the human renal cell line REPC Blood 117 2011 4905 4914
5. S.T. Koury, M.C. Bondurant, M.J. Koury, and G.L. Semenza Localization of cells producing erythropoietin in murine liver by in situ hybridization Blood 77 1991 2497 2503
6. C. Lacombe, J.L. Da Silva, P. Bruneval, J.G. Fournier, F. Wendling, and N. Casadevall Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney J Clin Invest 81 1988 620 623 (Pubitemid 18075261)
7. E.D. Zanjani, J. Poster, H. Burlington, L.I. Mann, and L.R. Wasserman Liver as the primary site of erythropoietin formation in the fetus J Lab Clin Med 89 1977 640 644 (Pubitemid 8082916)
8. G.L. Semenza, R.C. Dureza, M.D. Traystman, J.D. Gearhart, and S.E. Antonarakis Human erythropoietin gene expression in transgenic mice: multiple transcription initiation sites and cis-acting regulatory elements Mol Cell Biol 10 1990 930 938
9. M.A. Goldberg, G.A. Glass, J.M. Cunningham, and H.F. Bunn The regulated expression of erythropoietin by two human hepatoma cell lines Proc Natl Acad Sci USA 84 1987 7972 7976 (Pubitemid 17162815)
10. I. Beck, S. Ramirez, R. Weinmann, and J. Caro Enhancer element at the 3′-flanking region controls transcriptional response to hypoxia in the human erythropoietin gene J Biol Chem 266 1991 15563 15566 (Pubitemid 21907687)
11. G.L. Semenza, and G.L. Wang A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation Mol Cell Biol 12 1992 5447 5454
12. G.L. Wang, and G.L. Semenza General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia Proc Natl Acad Sci USA 90 1993 4304 4308 (Pubitemid 23134215)
13. G.L. Wang, and G.L. Semenza Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia J Biol Chem 268 1993 21513 21518 (Pubitemid 23320639)
14. P.P. Kapitsinou, Q. Liu, T.L. Unger, J. Rha, O. Davidoff, and B. Keith Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia Blood 116 2010 3039 3048
15. C. Warnecke, Z. Zaborowska, J. Kurreck, V.A. Erdmann, U. Frei, and M. Wiesener Differentiating the functional role of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2alpha target gene in Hep3B and Kelly cells FASEB J 18 2004 1462 1464 (Pubitemid 39561615)
16. O. Ohneda, M. Nagano, and Y. Fujii-Kuriyama Role of hypoxia-inducible factor-2alpha in endothelial development and hematopoiesis Methods Enzymol 435 2007 199 218
17. D.L. Galson, T. Tsuchiya, D.S. Tendler, L.E. Huang, Y. Ren, and T. Ogura The orphan receptor hepatic nuclear factor 4 functions as a transcriptional activator for tissue-specific and hypoxia-specific erythropoietin gene expression and is antagonized by EAR3/COUP-TF1 Mol Cell Biol 15 1995 2135 2144
18. K.L. Blanchard, A.M. Acquaviva, D.L. Galson, and H.F. Bunn Hypoxic induction of the human erythropoietin gene: cooperation between the promoter and enhancer, each of which contains steroid receptor response elements Mol Cell Biol 12 1992 5373 5385
19. S. Lee-Huang, J.J. Lin, H.F. Kung, P.L. Huang, and L. Lee The human erythropoietin-encoding gene contains a CAAT box, TATA boxes and other transcriptional regulatory elements in its 5′ flanking region Gene 128 1993 227 236 (Pubitemid 23189846)
20. S. Imagawa, M. Yamamoto, and Y. Miura Negative regulation of the erythropoietin gene expression by the GATA transcription factors Blood 89 1997 1430 1439 (Pubitemid 27080008)
21. K. La Ferla, C. Reimann, W. Jelkmann, and T. Hellwig-Burgel Inhibition of erythropoietin gene expression signaling involves the transcription factors GATA-2 and NF-kappaB FASEB J 16 2002 1811 1813
22. I. Buck, F. Morceau, S. Cristofanon, C. Heintz, S. Chateauvieux, and S. Reuter Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway GATA-1 and FOG-1 downregulation and GATA-2 upregulation Biochem Pharmacol 76 2008 1229 1239
23. I. Buck, F. Morceau, S. Cristofanon, S. Reuter, M. Dicato, and M. Diederich The inhibitory effect of the proinflammatory cytokine TNFalpha on erythroid differentiation involves erythroid transcription factor modulation Int J Oncol 34 2009 853 860
24. C. Grigorakaki, F. Morceau, S. Chateauvieux, M. Dicato, and M. Diederich Tumor necrosis factor alpha-mediated inhibition of erythropoiesis involves GATA-1/GATA-2 balance impairment and PU.1 over-expression Biochem Pharmacol 82 2011 156 166
25. S.N. Constantinescu, T. Keren, M. Socolovsky, H. Nam, Y.I. Henis, and H.F. Lodish Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain Proc Natl Acad Sci USA 98 2001 4379 4384 (Pubitemid 32294985)
26. J.L. Spivak The anaemia of cancer: death by a thousand cuts Nat Rev Cancer 5 2005 543 555 (Pubitemid 40942830)
27. B.A. Witthuhn, F.W. Quelle, O. Silvennoinen, T. Yi, B. Tang, and O. Miura JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin Cell 74 1993 227 236 (Pubitemid 23221699)
28. S.J. Frank Receptor dimerization in GH and erythropoietin action - it takes two to tango, but how? Endocrinology 143 2002 2 10 (Pubitemid 34056396)
29. H. Bao, S.M. Jacobs-Helber, A.E. Lawson, K. Penta, A. Wickrema, and S.T. Sawyer Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells) Blood 93 1999 3757 3773 (Pubitemid 29249822)
30. D.M. Wojchowski, R.C. Gregory, C.P. Miller, A.K. Pandit, and T.J. Pircher Signal transduction in the erythropoietin receptor system Exp Cell Res 253 1999 143 156
31. H. Huddleston, B. Tan, F.C. Yang, H. White, M.J. Wenning, and A. Orazi Functional p85alpha gene is required for normal murine fetal erythropoiesis Blood 102 2003 142 145 (Pubitemid 36759647)
32. W. Zhao, C. Kitidis, M.D. Fleming, H.F. Lodish, and S. Ghaffari Erythropoietin stimulates phosphorylation and activation of GATA-1 via the PI3-kinase/AKT signaling pathway Blood 107 2006 907 915 (Pubitemid 43158401)
33. T. Gregory, C. Yu, A. Ma, S.H. Orkin, G.A. Blobel, and M.J. Weiss GATA-1 and erythropoietin cooperate to promote erythroid cell survival by regulating bcl-xL expression Blood 94 1999 87 96 (Pubitemid 29300137)
34. K.E. Nichols, J.D. Crispino, M. Poncz, J.G. White, S.H. Orkin, and J.M. Maris Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1 Nat Genet 24 2000 266 270 (Pubitemid 30132195)
35. M.C. Simon, L. Pevny, M.V. Wiles, G. Keller, F. Costantini, and S.H. Orkin Rescue of erythroid development in gene targeted GATA-1-mouse embryonic stem cells Nat Genet 1 1992 92 98
36. W.J. Bakker, M. Blazquez-Domingo, A. Kolbus, J. Besooyen, P. Steinlein, and H. Beug FoxO3a regulates erythroid differentiation and induces BTG1, an activator of protein arginine methyl transferase 1 J Cell Biol 164 2004 175 184 (Pubitemid 38133938)
37. D. Bouscary, F. Pene, Y.E. Claessens, O. Muller, S. Chretien, and M. Fontenay-Roupie Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation Blood 101 2003 3436 3443 (Pubitemid 36857926)
38. Y. Kashii, M. Uchida, K. Kirito, M. Tanaka, K. Nishijima, and M. Toshima A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction Blood 96 2000 941 949 (Pubitemid 30616858)
39. H. Lei, and F.W. Quelle FOXO transcription factors enforce cell cycle checkpoints and promote survival of hematopoietic cells after DNA damage Mol Cancer Res 7 2009 1294 1303
40. R. Haq, A. Halupa, B.K. Beattie, J.M. Mason, B.W. Zanke, and D.L. Barber Regulation of erythropoietin-induced STAT serine phosphorylation by distinct mitogen-activated protein kinases J Biol Chem 277 2002 17359 17366 (Pubitemid 34967772)
41. A. Kolbus, S. Pilat, Z. Husak, E.M. Deiner, G. Stengl, and H. Beug Raf-1 antagonizes erythroid differentiation by restraining caspase activation J Exp Med 196 2002 1347 1353 (Pubitemid 35375553)
42. Y. Zermati, C. Garrido, S. Amsellem, S. Fishelson, D. Bouscary, and F. Valensi Caspase activation is required for terminal erythroid differentiation J Exp Med 193 2001 247 254 (Pubitemid 32524456)
43. S. Uddin, J. Ah-Kang, J. Ulaszek, D. Mahmud, and A. Wickrema Differentiation stage-specific activation of p38 mitogen-activated protein kinase isoforms in primary human erythroid cells Proc Natl Acad Sci USA 101 2004 147 152 (Pubitemid 38084218)
44. S.M. Jacobs-Helber, J.J. Ryan, and S.T. Sawyer JNK p38 are activated by erythropoietin (EPO) but are not induced in apoptosis following EPO withdrawal in EPO-dependent HCD57 cells Blood 96 2000 933 940 (Pubitemid 30616857)
45. Y. Nagata, N. Takahashi, R.J. Davis, and K. Todokoro Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation Blood 92 1998 1859 1869 (Pubitemid 28446674)
46. I. Buck, F. Morceau, C. Grigorakaki, M. Dicato, and M. Diederich Linking anemia to inflammation and cancer: the crucial role of TNFalpha Biochem Pharmacol 77 2009 1572 1579
47. F. Morceau, M. Dicato, and M. Diederich Pro-inflammatory cytokine-mediated anemia: regarding molecular mechanisms of erythropoiesis Mediators Inflamm 2009 2009 405016
48. B.B. Aggarwal Signalling pathways of the TNF superfamily: a double-edged sword Nat Rev Immunol 3 2003 745 756 (Pubitemid 41070815)
49. T. Yuasa, S. Ohno, J.H. Kehrl, and J.M. Kyriakis Tumor necrosis factor signaling to stress-activated protein kinase (SAPK)/Jun NH2-terminal kinase (JNK) and p38. Germinal center kinase couples TRAF2 to mitogen-activated protein kinase/ERK kinase kinase 1 and SAPK while receptor interacting protein associates with a mitogen-activated protein kinase kinase kinase upstream of MKK6 and p38 J Biol Chem 273 1998 22681 22692 (Pubitemid 28399839)
50. J.Y. Cheung, and B.A. Miller Molecular mechanisms of erythropoietin signaling Nephron 87 2001 215 222 (Pubitemid 32268562)
51. S.N. Constantinescu, S. Ghaffari, and H.F. Lodish The erythropoietin receptor: structure, activation and intracellular signal transduction Trends Endocrinol Metab 10 1999 18 23 (Pubitemid 29288706)
52. M. Socolovsky, H. Nam, M.D. Fleming, V.H. Haase, C. Brugnara, and H.F. Lodish Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts Blood 98 2001 3261 3273
53. C. James, V. Ugo, J.P. Le Couedic, J. Staerk, F. Delhommeau, and C. Lacout A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera Nature 434 2005 1144 1148 (Pubitemid 40663494)
54. U. Klingmuller, U. Lorenz, L.C. Cantley, B.G. Neel, and H.F. Lodish Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals Cell 80 1995 729 738
55. L. Garcon, C. Rivat, C. James, C. Lacout, V. Camara-Clayette, and V. Ugo Constitutive activation of STAT5 and Bcl-xL overexpression can induce endogenous erythroid colony formation in human primary cells Blood 108 2006 1551 1554 (Pubitemid 44316120)
56. M.O. Arcasoy, K.W. Harris, and B.G. Forget A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation Exp Hematol 27 1999 63 74 (Pubitemid 29123982)
57. S.S. Watowich, X. Xie, U. Klingmuller, J. Kere, M. Lindlof, and S. Berglund Erythropoietin receptor mutations associated with familial erythrocytosis cause hypersensitivity to erythropoietin in the heterozygous state Blood 94 1999 2530 2532 (Pubitemid 29467703)
58. J.P. Laubach, P. Fu, X. Jiang, K.H. Salter, A. Potti, and M.O. Arcasoy Polycythemia vera erythroid precursors exhibit increased proliferation and apoptosis resistance associated with abnormal RAS and PI3K pathway activation Exp Hematol 37 2009 1411 1422
59. T. Miyake, C.K. Kung, and E. Goldwasser Purification of human erythropoietin J Biol Chem 252 1977 5558 5564 (Pubitemid 8167007)
60. K. Jacobs, C. Shoemaker, R. Rudersdorf, S.D. Neill, R.J. Kaufman, and A. Mufson Isolation and characterization of genomic and cDNA clones of human erythropoietin Nature 313 1985 806 810 (Pubitemid 15130833)
61. F.K. Lin, S. Suggs, C.H. Lin, J.K. Browne, R. Smalling, and J.C. Egrie Cloning and expression of the human erythropoietin gene Proc Natl Acad Sci USA 82 1985 7580 7584 (Pubitemid 16204391)
62. T. Drueke Hyporesponsiveness to recombinant human erythropoietin Nephrol Dial Transplant 16 Suppl 7 2001 25 28 [Official publication of the European Dialysis and Transplant Association - European Renal Association] (Pubitemid 33062119)
63. I.C. Macdougall, and A.C. Cooper Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines Nephrol Dial Transplant 17 Suppl 11 2002 39 43 [Official publication of the European Dialysis and Transplant Association - European Renal Association] (Pubitemid 35277063)
64. I.C. Macdougall, and A.C. Cooper Hyporesponsiveness to erythropoietic therapy due to chronic inflammation Eur J Clin Invest 35 Suppl 3 2005 32 35 (Pubitemid 41783602)
65. N. Casadevall, J. Nataf, B. Viron, A. Kolta, J.J. Kiladjian, and P. Martin-Dupont Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin N Engl J Med 346 2002 469 475 (Pubitemid 34441737)
66. M.J. Cervelli, N. Gray, S. McDonald, M.G. Gentgall, and A.P. Disney Randomized cross-over comparison of intravenous and subcutaneous darbepoetin dosing efficiency in haemodialysis patients Nephrology 10 2005 129 135 (Pubitemid 40776271)
67. J.C. Egrie, and J.K. Browne Development and characterization of novel erythropoiesis stimulating protein (NESP) Nephrol Dial Transplant 16 Suppl 3 2001 3 13 [Official publication of the European Dialysis and Transplant Association - European Renal Association] (Pubitemid 32591159)
68. J. Glaspy, S. Vadhan-Raj, R. Patel, L. Bosserman, E. Hu, and R.E. Lloyd Randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia: the 20030125 Study Group Trial J Clin Oncol 24 2006 2290 2297 [Official journal of the American Society of Clinical Oncology] (Pubitemid 46630659)
69. B. Ling, M. Walczyk, A. Agarwal, W. Carroll, W. Liu, and R. Brenner Darbepoetin alfa administered once monthly maintains hemoglobin concentrations in patients with chronic kidney disease Clin Nephrol 63 2005 327 334 (Pubitemid 40668225)
70. A.P. Maxwell Novel erythropoiesis-stimulating protein in the management of the anemia of chronic renal failure Kidney Int 62 2002 720 729 (Pubitemid 34779787)
71. G.G. Kochendoerfer, S.Y. Chen, F. Mao, S. Cressman, S. Traviglia, and H. Shao Design and chemical synthesis of a homogeneous polymer-modified erythropoiesis protein Science 299 2003 884 887 (Pubitemid 36182445)
72. I.C. Macdougall CERA (Continuous Erythropoietin Receptor Activator): a new erythropoiesis-stimulating agent for the treatment of anemia Curr Hematol Rep 4 2005 436 440
73. A.J. Sytkowski, E.D. Lunn, M.A. Risinger, and K.L. Davis An erythropoietin fusion protein comprised of identical repeating domains exhibits enhanced biological properties J Biol Chem 274 1999 24773 24778
74. A.J. Sytkowski, E.D. Lunn, K.L. Davis, L. Feldman, and S. Siekman Human erythropoietin dimers with markedly enhanced in vivo activity Proc Natl Acad Sci USA 95 1998 1184 1188 (Pubitemid 28124933)
75. Q. Fan, K.K. Leuther, C.P. Holmes, K.L. Fong, J. Zhang, and S. Velkovska Preclinical evaluation of Hematide, a novel erythropoiesis stimulating agent, for the treatment of anemia Exp Hematol 34 2006 1303 1311 (Pubitemid 44389891)
76. K.W. Woodburn, Q. Fan, S. Winslow, M.J. Chen, R.B. Mortensen, and N. Casadevall Hematide is immunologically distinct from erythropoietin and corrects anemia induced by antierythropoietin antibodies in a rat pure red cell aplasia model Exp Hematol 35 2007 1201 1208 (Pubitemid 47088782)
77. I.C. Macdougall, J. Rossert, N. Casadevall, R.B. Stead, A.M. Duliege, and M. Froissart A peptide-based erythropoietin-receptor agonist for pure red-cell aplasia N Engl J Med 361 2009 1848 1855
78. F. Locatelli, and L. Del Vecchio Hematide for the treatment of chronic kidney disease-related anemia Expert Rev Hematol 2 2009 377 383
79. R.B. Stead, J. Lambert, D. Wessels, J.S. Iwashita, K.K. Leuther, and K.W. Woodburn Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers Blood 108 2006 1830 1834 (Pubitemid 44394989)
80. L. Yan, V.J. Colandrea, and J.J. Hale Prolyl hydroxylase domain-containing protein inhibitors as stabilizers of hypoxia-inducible factor: small molecule-based therapeutics for anemia Expert Opin Ther Pat 20 2010 1219 1245
81. J. Fandrey, and M. Dicato Examining the involvement of erythropoiesis-stimulating agents in tumor proliferation (erythropoietin receptors, receptor binding, signal transduction), angiogenesis, and venous thromboembolic events Oncologist 14 Suppl 1 2009 34 42
82. C. Lundby, and N.V. Olsen Effects of recombinant human erythropoietin in normal humans J Physiol 589 2011 1265 1271
83. S. Masuda, M. Nagao, K. Takahata, Y. Konishi, F. Gallyas Jr., and T. Tabira Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells J Biol Chem 268 1993 11208 11216 (Pubitemid 23162313)
84. P.T. Jubinsky, O.I. Krijanovski, D.G. Nathan, J. Tavernier, and C.A. Sieff The beta chain of the interleukin-3 receptor functionally associates with the erythropoietin receptor Blood 90 1997 1867 1873 (Pubitemid 27377296)
85. M. Brines, G. Grasso, F. Fiordaliso, A. Sfacteria, P. Ghezzi, and M. Fratelli Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor Proc Natl Acad Sci USA 101 2004 14907 14912 (Pubitemid 39410773)
86. M. Um, A.W. Gross, and H.F. Lodish "A classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells Cell Signal 19 2007 634 645 (Pubitemid 46107815)
87. M. Leist, P. Ghezzi, G. Grasso, R. Bianchi, P. Villa, and M. Fratelli Derivatives of erythropoietin that are tissue protective but not erythropoietic Science 305 2004 239 242 (Pubitemid 38886736)
88. R. Imamura, M. Okumi, Y. Isaka, N. Ichimaru, T. Moriyama, and E. Imai Carbamylated erythropoietin improves angiogenesis and protects the kidneys from ischemia-reperfusion injury Cell Transplant 17 2008 135 141 (Pubitemid 351551389)
89. T. Sato, M. Tanno, T. Miki, T. Yano, K. Shimamoto, and T. Miura Erythropoietin (EPO) affords more potent cardioprotection by activation of distinct signaling to mitochondrial kinases compared with carbamylated EPO Cardiovasc Drugs Ther 24 2010 401 408 [Sponsored by the International Society of Cardiovascular Pharmacotherapy]
90. P. Villa, J. van Beek, A.K. Larsen, J. Gerwien, S. Christensen, and A. Cerami Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives J Cereb Blood Flow Metab 27 2007 552 563 [Official journal of the International Society of Cerebral Blood Flow and Metabolism]
91. A. Kirkeby, L. Torup, L. Bochsen, M. Kjalke, K. Abel, and K. Theilgaard-Monch High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO) Thromb Haemost 99 2008 720 728 (Pubitemid 351694228)
92. M. Brines, N.S. Patel, P. Villa, C. Brines, T. Mennini, and M. De Paola Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin Proc Natl Acad Sci USA 105 2008 10925 10930
93. F. Dumont, and P. Bischoff Non-erythropoietic tissue-protective peptides derived from erythropoietin: WO2009094172 Expert Opin Ther Pat 20 2010 715 723
94. H. Ueba, M. Brines, M. Yamin, T. Umemoto, J. Ako, and S. Momomura Cardioprotection by a nonerythropoietic, tissue-protective peptide mimicking the 3D structure of erythropoietin Proc Natl Acad Sci USA 107 2010 14357 14362
95. R. Ramirez, J. Carracedo, S. Nogueras, P. Buendia, A. Merino, and S. Canadillas Carbamylated darbepoetin derivative prevents endothelial progenitor cell damage with no effect on angiogenesis J Mol Cell Cardiol 47 2009 781 788
96. S. Erbayraktar, G. Grasso, A. Sfacteria, Q.W. Xie, T. Coleman, and M. Kreilgaard Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo Proc Natl Acad Sci USA 100 2003 6741 6746 (Pubitemid 36666650)
97. P. Colella, C. Iodice, U. Di Vicino, I. Annunziata, E.M. Surace, and A. Auricchio Non-erythropoietic erythropoietin derivatives protect from light-induced and genetic photoreceptor degeneration Hum Mol Genet 2011
98. M. Digicaylioglu, S. Bichet, H.H. Marti, R.H. Wenger, L.A. Rivas, and C. Bauer Localization of specific erythropoietin binding sites in defined areas of the mouse brain Proc Natl Acad Sci USA 92 1995 3717 3720
99. S.E. Juul, A.T. Yachnis, A.M. Rojiani, and R.D. Christensen Immunohistochemical localization of erythropoietin and its receptor in the developing human brain Pediatr Dev Pathol 2 1999 148 158 (Pubitemid 29130201)
100. R. Depping, K. Kawakami, H. Ocker, J.M. Wagner, M. Heringlake, and A. Noetzold Expression of the erythropoietin receptor in human heart J Thorac Cardiovasc Surg 130 2005 877 878
101. S.E. Juul, A.E. Joyce, Y. Zhao, and D.J. Ledbetter Why is erythropoietin present in human milk? Studies of erythropoietin receptors on enterocytes of human and rat neonates Pediatr Res 46 1999 263 268 (Pubitemid 29400568)
102. Y. Yasuda, S. Masuda, M. Chikuma, K. Inoue, M. Nagao, and R. Sasaki Estrogen-dependent production of erythropoietin in uterus and its implication in uterine angiogenesis J Biol Chem 273 1998 25381 25387 (Pubitemid 28443305)
103. C. Westenfelder, D.L. Biddle, and R.L. Baranowski Human, rat, and mouse kidney cells express functional erythropoietin receptors Kidney Int 55 1999 808 820 (Pubitemid 29100693)
104. E.S. Fenjves, M.S. Ochoa, O. Cabrera, A.J. Mendez, N.S. Kenyon, and L. Inverardi Human, nonhuman primate, and rat pancreatic islets express erythropoietin receptors Transplantation 75 2003 1356 1360 (Pubitemid 36513048)
105. H. Kin, Z.Q. Zhao, H.Y. Sun, N.P. Wang, J.S. Corvera, and M.E. Halkos Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion Cardiovasc Res 62 2004 74 85 (Pubitemid 38326813)
106. S. Tamareille, N. Ghaboura, F. Treguer, D. Khachman, A. Croue, and D. Henrion Myocardial reperfusion injury management: erythropoietin compared with postconditioning Am J Physiol Heart Circ Physiol 297 2009 H2035 H2043
107. M. Mengozzi, R. Latini, M. Salio, A. Sfacteria, G. Piedimonte, and J.G. Gerwien Increased erythropoietin production after myocardial infarction in mice Heart 92 2006 838 839 (Pubitemid 43799229)
108. D. Tekin, A.D. Dursun, and L. Xi Hypoxia inducible factor 1 (HIF-1) and cardioprotection Acta Pharmacol Sin 31 2010 1085 1094
109. Z. Cai, D.J. Manalo, G. Wei, E.R. Rodriguez, K. Fox-Talbot, and H. Lu Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury Circulation 108 2003 79 85 (Pubitemid 36859024)
110. L. Calvillo, R. Latini, J. Kajstura, A. Leri, P. Anversa, and P. Ghezzi Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling Proc Natl Acad Sci USA 100 2003 4802 4806 (Pubitemid 36457809)
111. C. Moon, M. Krawczyk, D. Ahn, I. Ahmet, D. Paik, and E.G. Lakatta Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats Proc Natl Acad Sci USA 100 2003 11612 11617 (Pubitemid 37205984)
112. C.J. Parsa, A. Matsumoto, J. Kim, R.U. Riel, L.S. Pascal, and G.B. Walton A novel protective effect of erythropoietin in the infarcted heart J Clin Invest 112 2003 999 1007 (Pubitemid 38056315)
113. A.F. Tramontano, R. Muniyappa, A.D. Black, M.C. Blendea, I. Cohen, and L. Deng Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway Biochem Biophys Res Commun 308 2003 990 994 (Pubitemid 36976556)
114. G.L. Wright, P. Hanlon, K. Amin, C. Steenbergen, E. Murphy, and M.O. Arcasoy Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury FASEB J 18 2004 1031 1033 (Pubitemid 39561515)
115. Y. Shi, P. Rafiee, J. Su, K.A. Pritchard Jr., J.S. Tweddell, and J.E. Baker Acute cardioprotective effects of erythropoietin in infant rabbits are mediated by activation of protein kinases and potassium channels Basic Res Cardiol 99 2004 173 182 (Pubitemid 38594226)
116. A. Chatagner, P.S. Huppi, R. Ha-Vinh Leuchter, and S. Sizonenko Erythropoietin and neuroprotection Arch Pediatr 17 Suppl 3 2010 S78 S84
117. M.H. Cardone, N. Roy, H.R. Stennicke, G.S. Salvesen, T.F. Franke, and E. Stanbridge Regulation of cell death protease caspase-9 by phosphorylation Science 282 1998 1318 1321 (Pubitemid 28524494)
118. S.R. Datta, H. Dudek, X. Tao, S. Masters, H. Fu, and Y. Gotoh Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery Cell 91 1997 231 241 (Pubitemid 27456390)
119. K. Shivakumar, S.J. Sollott, M. Sangeetha, S. Sapna, B. Ziman, and S. Wang Paracrine effects of hypoxic fibroblast-derived factors on the MPT-ROS threshold and viability of adult rat cardiac myocytes Am J Physiol Heart Circ Physiol 294 2008 H2653 H2658
120. D. Burger, A. Xenocostas, and Q.P. Feng Molecular basis of cardioprotection by erythropoietin Curr Mol Pharmacol 2 2009 56 69
121. T. Rui, Q. Feng, M. Lei, T. Peng, J. Zhang, and M. Xu Erythropoietin prevents the acute myocardial inflammatory response induced by ischemia/reperfusion via induction of AP-1 Cardiovasc Res 65 2005 719 727 (Pubitemid 40138993)
122. Y. Li, G. Takemura, H. Okada, S. Miyata, R. Maruyama, and L. Li Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure Cardiovasc Res 71 2006 684 694 (Pubitemid 44848006)
123. X. Liu, W. Xie, P. Liu, M. Duan, Z. Jia, and W. Li Mechanism of the cardioprotection of rhEPO pretreatment on suppressing the inflammatory response in ischemia-reperfusion Life Sci 78 2006 2255 2264
124. L. Li, G. Takemura, Y. Li, S. Miyata, M. Esaki, and H. Okada Preventive effect of erythropoietin on cardiac dysfunction in doxorubicin-induced cardiomyopathy Circulation 113 2006 535 543
125. X. Liu, Z. Zhou, X. Feng, Z. Jia, Y. Jin, and J. Xu Cyclooxygenase-2 plays an essential part in cardioprotection of delayed phase of recombinant human erythropoietin preconditioning in rats Postgrad Med J 82 2006 588 593 (Pubitemid 44476216)
126. D. Burger, M. Lei, N. Geoghegan-Morphet, X. Lu, A. Xenocostas, and Q. Feng Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase Cardiovasc Res 72 2006 51 59 (Pubitemid 44310637)
127. F. Dodd, M. Limoges, R.T. Boudreau, G. Rowden, P.R. Murphy, and C.K. Too L-arginine inhibits apoptosis via a NO-dependent mechanism in Nb2 lymphoma cells J Cell Biochem 77 2000 624 634 (Pubitemid 30332002)
128. Y.M. Kim, T.H. Kim, H.T. Chung, R.V. Talanian, X.M. Yin, and T.R. Billiar Nitric oxide prevents tumor necrosis factor alpha-induced rat hepatocyte apoptosis by the interruption of mitochondrial apoptotic signaling through S-nitrosylation of caspase-8 Hepatology 32 2000 770 778
129. B.B. Beleslin-Cokic, V.P. Cokic, X. Yu, B.B. Weksler, A.N. Schechter, and C.T. Noguchi Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells Blood 104 2004 2073 2080 (Pubitemid 39297859)
130. P. Fu, and M.O. Arcasoy Erythropoietin protects cardiac myocytes against anthracycline-induced apoptosis Biochem Biophys Res Commun 354 2007 372 378 (Pubitemid 46161367)
131. K.H. Kim, G.Y. Oudit, and P.H. Backx Erythropoietin protects against doxorubicin-induced cardiomyopathy via a phosphatidylinositol 3-kinase-dependent pathway J Pharmacol Exp Ther 324 2008 160 169 (Pubitemid 350294149)
132. A. Anagnostou, E.S. Lee, N. Kessimian, R. Levinson, and M. Steiner Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells Proc Natl Acad Sci USA 87 1990 5978 5982
133. A. Anagnostou, Z. Liu, M. Steiner, K. Chin, E.S. Lee, and N. Kessimian Erythropoietin receptor mRNA expression in human endothelial cells Proc Natl Acad Sci USA 91 1994 3974 3978 (Pubitemid 24139555)
134. D. Ribatti, M. Presta, A. Vacca, R. Ria, R. Giuliani, and P. Dell'Era Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo Blood 93 1999 2627 2636 (Pubitemid 29181195)
135. M. Nakano, K. Satoh, Y. Fukumoto, Y. Ito, Y. Kagaya, and N. Ishii Important role of erythropoietin receptor to promote VEGF expression and angiogenesis in peripheral ischemia in mice Circ Res 100 2007 662 669 (Pubitemid 46594880)
136. J.S. Lin, Y.S. Chen, H.S. Chiang, and M.C. Ma Hypoxic preconditioning protects rat hearts against ischaemia-reperfusion injury: role of erythropoietin on progenitor cell mobilization J Physiol 586 2008 5757 5769
137. K. Ueda, H. Takano, Y. Niitsuma, H. Hasegawa, R. Uchiyama, and T. Oka Sonic hedgehog is a critical mediator of erythropoietin-induced cardiac protection in mice J Clin Invest 120 2010 2016 2029
138. R. Teng, J.W. Calvert, N. Sibmooh, B. Piknova, N. Suzuki, and J. Sun Acute erythropoietin cardioprotection is mediated by endothelial response Basic Res Cardiol 106 2011 343 354
139. D.J. Hausenloy, and D.M. Yellon New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway Cardiovasc Res 61 2004 448 460 (Pubitemid 38210151)
140. N. Ghaboura, S. Tamareille, P.H. Ducluzeau, L. Grimaud, L. Loufrani, and A. Croue Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3beta signaling Basic Res Cardiol 106 2011 147 162
141. C. Liu, K. Shen, Z. Liu, and C.T. Noguchi Regulated human erythropoietin receptor expression in mouse brain J Biol Chem 272 1997 32395 32400 (Pubitemid 28011922)
142. P.T. Tsai, J.J. Ohab, N. Kertesz, M. Groszer, C. Matter, and J. Gao A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery J Neurosci 26 2006 1269 1274 (Pubitemid 43237059)
143. T. Shingo, S.T. Sorokan, T. Shimazaki, and S. Weiss Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells J Neurosci 21 2001 9733 9743 (Pubitemid 34184059)
144. L. Wang, Z. Zhang, Y. Wang, R. Zhang, and M. Chopp Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats Stroke 35 2004 1732 1737 (Pubitemid 38823656)
145. M. Iwai, G. Cao, W. Yin, R.A. Stetler, J. Liu, and J. Chen Erythropoietin promotes neuronal replacement through revascularization and neurogenesis after neonatal hypoxia/ischemia in rats Stroke 38 2007 2795 2803 (Pubitemid 47494020)
146. S.E. Juul, R.J. McPherson, F.X. Farrell, L. Jolliffe, D.J. Ness, and C.A. Gleason Erytropoietin concentrations in cerebrospinal fluid of nonhuman primates and fetal sheep following high-dose recombinant erythropoietin Biol Neonate 85 2004 138 144 (Pubitemid 38437682)
147. M. Bernaudin, A. Bellail, H.H. Marti, A. Yvon, D. Vivien, and I. Duchatelle Neurons and astrocytes express EPO mRNA: oxygen-sensing mechanisms that involve the redox-state of the brain Glia 30 2000 271 278 (Pubitemid 30259666)
148. D.M. Ferriero Neonatal brain injury N Engl J Med 351 2004 1985 1995
149. L. Wei, B.H. Han, Y. Li, C.L. Keogh, D.M. Holtzman, and S.P. Yu Cell death mechanism and protective effect of erythropoietin after focal ischemia in the whisker-barrel cortex of neonatal rats J Pharmacol Exp Ther 317 2006 109 116
150. E. Spandou, V. Soubasi, S. Papoutsopoulou, G. Karkavelas, C. Simeonidou, and A. Kaiki-Astara Erythropoietin prevents hypoxia/ischemia-induced DNA fragmentation in an experimental model of perinatal asphyxia Neurosci Lett 366 2004 24 28 (Pubitemid 38953141)
151. A. Kumral, S. Genc, E. Ozer, O. Yilmaz, N. Gokmen, and T.F. Koroglu Erythropoietin downregulates bax and DP5 proapoptotic gene expression in neonatal hypoxic-ischemic brain injury Biol Neonate 89 2006 205 210
152. R.J. McPherson, and S.E. Juul Erythropoietin for infants with hypoxic-ischemic encephalopathy Curr Opin Pediatr 22 2010 139 145
153. X. Wang, C. Zhu, J.G. Gerwien, A. Schrattenholz, M. Sandberg, and M. Leist The nonerythropoietic asialoerythropoietin protects against neonatal hypoxia-ischemia as potently as erythropoietin J Neurochem 91 2004 900 910 (Pubitemid 39507367)
154. S.M. Lee, T.H. Nguyen, M.H. Park, K.S. Kim, K.J. Cho, and D.C. Moon EPO receptor-mediated ERK kinase and NF-kappaB activation in erythropoietin-promoted differentiation of astrocytes Biochem Biophys Res Commun 320 2004 1087 1095
155. M. Iwai, R.A. Stetler, J. Xing, X. Hu, Y. Gao, and W. Zhang Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic/ischemic brain injury Stroke 41 2010 1032 1037
156. N. Berkingali, A. Warnecke, P. Gomes, G. Paasche, J. Tack, and T. Lenarz Neurite outgrowth on cultured spiral ganglion neurons induced by erythropoietin Hear Res 243 2008 121 126
157. E. Taoufik, E. Petit, D. Divoux, V. Tseveleki, M. Mengozzi, and M.L. Roberts TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury Proc Natl Acad Sci USA 105 2008 6185 6190 (Pubitemid 351758420)
158. L. Wang, M. Chopp, H. Teng, M. Bolz, M.A. Francisco, and D.M. Aluigi Tumor necrosis factor alpha primes cerebral endothelial cells for erythropoietin-induced angiogenesis J Cereb Blood Flow Metab 31 2011 640 647
159. Y. Sun, J.W. Calvert, and J.H. Zhang Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration Stroke 36 2005 1672 1678 (Pubitemid 41098760)
160. A. Kumral, H. Baskin, D.C. Yesilirmak, B.U. Ergur, S. Aykan, and S. Genc Erythropoietin attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain Neonatology 92 2007 269 278 (Pubitemid 350125285)
161. Y. Shen, H.M. Yu, T.M. Yuan, W.Z. Gu, and Y.D. Wu Erythropoietin attenuates white matter damage, proinflammatory cytokine and chemokine induction in developing rat brain after intra-uterine infection Neuropathology 29 2009 528 535
162. N. Byts, A. Samoylenko, T. Fasshauer, M. Ivanisevic, L. Hennighausen, and H. Ehrenreich Essential role for Stat5 in the neurotrophic but not in the neuroprotective effect of erythropoietin Cell Death Differ 15 2008 783 792 (Pubitemid 351405083)
163. A. Kumral, K. Tugyan, S. Gonenc, K. Genc, S. Genc, and U. Sonmez Protective effects of erythropoietin against ethanol-induced apoptotic neurodegenaration and oxidative stress in the developing C57BL/6 mouse brain Brain Res Dev Brain Res 160 2005 146 156 (Pubitemid 41735121)
164. Y. Xiong, A. Mahmood, C. Qu, H. Kazmi, Z.G. Zhang, and C.T. Noguchi Erythropoietin improves histological and functional outcomes after traumatic brain injury in mice in the absence of the neural erythropoietin receptor J Neurotrauma 27 2010 205 215
165. D. Choi, S.A. Schroer, L. Wang, X. Wu, and M. Woo Erythropoietin provides diabetes protection through direct effects on pancreatic β cells ENDO 2010 The Endocrine Society Annual Meeting 2010
166. H. Shuai, J. Zhang, Y. Yu, and M. Zhang Expression of EPO receptor in pancreatic cells and its effect on cell apoptosis J Huazhong Univ Sci Technolog Med Sci 28 2008 49 51
167. H. Shuai, J. Zhang, J. Xie, M. Zhang, Y. Yu, and L. Zhang Erythropoietin protects pancreatic beta-cell line NIT-1 cells against cytokine-induced apoptosis via phosphatidylinositol 3-kinase/Akt signaling Endocr Res 36 2011 25 34
168. D. Choi, S.A. Schroer, S.Y. Lu, L. Wang, X. Wu, and Y. Liu Erythropoietin protects against diabetes through direct effects on pancreatic beta cells J Exp Med 207 2010 2831 2842
169. H. He, T. Wu, J. Xiong, K. Chen, and Z. Mo Effect of erythropoietin on the proliferation and apoptosis of neonatal porcine islet cells Zhong Nan Da Xue Xue Bao Yi Xue Ban 35 2010 1115 1122
170. B.H. Ucan, O. Irkorucu, G.K. Cakmak, O. Tascilar, I.O. Tekin, and S. Acikgoz Erythropoietin: a possible cytoprotective cytokine in acute necrotizing pancreatitis J Hepatobiliary Pancreat Surg 16 2009 530 537
171. C. Bose, and K.B. Udupa Erythropoietin enhancement of rat pancreatic tumor cell proliferation requires the activation of ERK and JNK signals Am J Physiol Cell Physiol 295 2008 C394 C405
172. C. Hernandez, A. Fonollosa, M. Garcia-Ramirez, M. Higuera, R. Catalan, and A. Miralles Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema Diabetes Care 29 2006 2028 2033 (Pubitemid 44871182)
173. L. Zhong, J. Bradley, W. Schubert, E. Ahmed, A.P. Adamis, and D.T. Shima Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice Invest Ophthalmol Vis Sci 48 2007 1212 1218 (Pubitemid 351261416)
174. S.E. Juul, A.T. Yachnis, and R.D. Christensen Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus Early Hum Dev 52 1998 235 249 (Pubitemid 28548695)
175. M. Garcia-Ramirez, C. Hernandez, and R. Simo Expression of erythropoietin and its receptor in the human retina: a comparative study of diabetic and nondiabetic subjects Diabetes Care 31 2008 1189 1194
176. M.M. Loeliger, A. Mackintosh, R. De Matteo, R. Harding, and S.M. Rees Erythropoietin protects the developing retina in an ovine model of endotoxin-induced retinal injury Invest Ophthalmol Vis Sci 52 2011 2656 2661
177. K.P. Sanghera, N. Mathalone, R. Baigi, E. Panov, D. Wang, and X. Zhao The PI3K/Akt/mTOR pathway mediates retinal progenitor cell survival under hypoxic and superoxide stress Mol Cell Neurosci 47 2011 145 153
178. H. Ren, N.Y. Liu, X.F. Song, Y.S. Ma, and X.Y. Zhai A novel specific application of pyruvate protects the mouse retina against white light damage: differential stabilization of HIF-1{alpha} and HIF-2{alpha} Invest Ophthalmol Vis Sci 52 2011 3112 3118
179. P. Caye-Thomasen, N. Wagner, B. Lidegaard Frederiksen, K. Asal, and J. Thomsen Erythropoietin and erythropoietin receptor expression in the guinea pig inner ear Hear Res 203 2005 21 27 (Pubitemid 40602812)
180. A. Monge, I. Nagy, S. Bonabi, S. Schmid, M. Gassmann, and D. Bodmer The effect of erythropoietin on gentamicin-induced auditory hair cell loss Laryngoscope 116 2006 312 316 (Pubitemid 44383945)
181. N. Andreeva, A. Nyamaa, H. Haupt, J. Gross, and B. Mazurek Recombinant human erythropoietin prevents ischemia-induced apoptosis and necrosis in explant cultures of the rat organ of Corti Neurosci Lett 396 2006 86 90 (Pubitemid 43276418)
182. M.M. McClure, S.W. Threlkeld, and R.H. Fitch Auditory processing and learning/memory following erythropoietin administration in neonatally hypoxic-ischemic injured rats Brain Res 1132 2007 203 209 (Pubitemid 46096444)
183. J.H. Holstein, M.D. Menger, C. Scheuer, C. Meier, U. Culemann, and R.J. Wirbel Erythropoietin (EPO): EPO-receptor signaling improves early endochondral ossification and mechanical strength in fracture healing Life Sci 80 2007 893 900 (Pubitemid 46186418)
184. C. Contaldo, C. Meier, A. Elsherbiny, Y. Harder, O. Trentz, and M.D. Menger Human recombinant erythropoietin protects the striated muscle microcirculation of the dorsal skinfold from postischemic injury in mice Am J Physiol Heart Circ Physiol 293 2007 H274 H283
185. C. Contaldo, N. Lindenblatt, A. Elsherbiny, D.C. Hogger, M.K. Borozadi, and S.T. Vetter Erythropoietin requires endothelial nitric oxide synthase to counteract TNF-[alpha]-induced microcirculatory dysfunction in murine striated muscle Shock 35 2011 315 321
186. H. Kitamura, Y. Isaka, Y. Takabatake, R. Imamura, C. Suzuki, and S. Takahara Nonerythropoietic derivative of erythropoietin protects against tubulointerstitial injury in a unilateral ureteral obstruction model Nephrol Dial Transplant 23 2008 1521 1528 (Pubitemid 351767745)